Ildong Pharmaceutical Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	64,845	72,267	53,258	52,146	135,586
Short-Term Investments	110	12,605	28,021	16,600	19,095
Trading Asset Securities	-	-	-	10,000	-
Cash & Short-Term Investments	64,955	84,872	81,279	78,746	154,681
Cash Growth	-23.47%	4.42%	3.22%	-49.09%	79.52%
Accounts Receivable	46,852	44,613	56,245	53,916	51,818
Other Receivables	3,576	10,073	2,735	4,158	3,026
Receivables	51,096	66,977	62,650	58,074	54,844
Inventory	100,524	87,939	84,623	98,249	82,587
Prepaid Expenses	578.69	2,150	1,623	1,270	1,363
Other Current Assets	4,812	5,053	5,506	45,697	7,008
Total Current Assets	221,965	246,991	235,681	282,035	300,485
Property, Plant & Equipment	220,696	221,443	256,380	255,317	247,790
Long-Term Investments	47,696	23,729	18,996	21,395	22,432
Goodwill	5,527	5,527	5,527	5,527	5,527
Other Intangible Assets	17,163	22,681	30,079	31,401	38,926
Long-Term Accounts Receivable	-	277.34	442.14	542.83	-
Long-Term Deferred Tax Assets	46,708	55,670	53,888	43,822	66,016
Long-Term Deferred Charges	6,122	6,151	6,505	10,193	22,174
Other Long-Term Assets	6,096	4,590	1,689	3,630	3,808
Total Assets	573,031	589,043	611,261	655,810	708,970
Accounts Payable	47,761	47,616	50,250	46,099	38,334
Accrued Expenses	27,749	30,985	33,277	33,734	34,930
Short-Term Debt	82,413	122,647	176,497	140,743	88,400
Current Portion of Long-Term Debt	33,535	3,443	13,000	1,000	42,000
Current Portion of Leases	4,878	4,606	3,575	6,618	4,035
Current Income Taxes Payable	986.98	1,475	68.3	268.05	7.55
Current Unearned Revenue	-	-	-	-	600
Other Current Liabilities	27,745	57,969	64,728	82,182	149,456
Total Current Liabilities	225,069	268,739	341,395	310,644	357,763
Long-Term Debt	2,673	56,208	3,000	16,000	60,404
Long-Term Leases	20,908	18,644	16,654	43,387	31,316
Pension & Post-Retirement Benefits	67,547	66,150	62,185	72,215	82,149
Long-Term Deferred Tax Liabilities	372.56	393.05	1.43	6.06	-
Other Long-Term Liabilities	11,047	12,623	8,644	9,688	10,375
Total Liabilities	327,617	422,758	431,880	451,940	542,008
Common Stock	31,638	28,063	28,063	26,803	23,803
Additional Paid-In Capital	95,380	173,327	173,359	377,287	210,262
Retained Earnings	105,717	-50,942	-58,540	-211,102	-81,951
Treasury Stock	-2,308	-2,307	-2,307	-365.05	-365.05
Comprehensive Income & Other	15,995	12,618	28,968	-1,379	1,159
Total Common Equity	246,422	160,758	169,543	191,244	152,909
Minority Interest	-6,909	-1,701	4,723	6,981	7,676
Shareholders' Equity	245,414	166,285	179,381	203,870	166,962
Total Liabilities & Equity	573,031	589,043	611,261	655,810	708,970
Total Debt	144,408	205,548	212,726	207,748	226,155
Net Cash (Debt)	-79,452	-120,675	-131,447	-129,002	-71,474
Net Cash Per Share	-2585.64	-4320.27	-4862.98	-4896.88	-3004.97
Filing Date Shares Outstanding	31.51	27.93	27.93	26.79	23.79
Total Common Shares Outstanding	31.51	27.93	27.93	26.79	23.79
Working Capital	-3,104	-21,748	-105,713	-28,609	-57,279
Book Value Per Share	7820.92	5755.27	6069.76	7139.87	6428.69
Tangible Book Value	223,732	132,550	133,936	154,315	108,456
Tangible Book Value Per Share	7100.80	4745.41	4795.03	5761.20	4559.77
Land	50,816	50,816	72,561	35,125	35,125
Buildings	142,902	140,049	141,614	140,941	140,732
Machinery	197,365	202,503	211,982	206,257	195,601
Construction In Progress	1,471	1,393	3,694	1,963	3,683

Source: S&P Global Market Intelligence. Standard template. Financial Sources.